These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37947342)

  • 1. Primary Site Surgery in Distantly Metastatic Oropharyngeal Squamous Cell Carcinoma.
    Carey RM; Prasad A; Wei K; Brant JA; Brody RM; Leibowitz JM; Civantos FJ; Sweeny L
    Laryngoscope; 2024 May; 134(5):2243-2251. PubMed ID: 37947342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Shiao JC; Holt D; Ladbury C; Gao D; Jones B; Karam SD; Amini A
    Oral Oncol; 2022 Jul; 130():105907. PubMed ID: 35605559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
    Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
    J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy in Metastatic Oropharyngeal Cancer.
    Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
    Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
    Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
    Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
    Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
    Huo Z; Fu S; Ma C; Sheng S
    BMC Cancer; 2022 May; 22(1):535. PubMed ID: 35549914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
    Wright CM; Lee DY; Shimunov D; Carmona R; Barsky AR; Sun L; Cohen RB; Bauml JM; Brody RM; Basu D; Rassekh CH; Chalian AA; Newman JG; Rajasekaran K; Weinstein GS; Lukens JN; Lin A; Swisher-McClure S
    Oral Oncol; 2021 Oct; 121():105509. PubMed ID: 34474270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Kitahara T; Hasegawa Y
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.